Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer
PaperCitations, authors & open-access status
Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 174 citations, 2023 year and green oa status.
174
Citations
2023
Year
green
OA Status